PreferredStockChannel
Preferred Stock Offerings
By Preferred Stock Channel Staff, updated Sun, August 14, 9:47 PM
| This Slide: #88 of 582 |
Slide #88. Boston Scientific Corporation — Preferred Stock Offering
Company:
Boston Scientific Corporation (NYSE:BSX)
Date announced:
5/21/2020
Shares Offered:
25,550,000
Date of Pricing:
5/21/2020
Price Per Share:
$34.25
Preferred Stock Offering Details:
Boston Scientific Corporation (NYSE: BSX) announced the pricing of concurrent offerings of 25,550,000 shares of its common stock ("Common Stock") at a price to the public of $34.25 per share and 8,750,000 shares of its 5.50% Mandatory Convertible Preferred Stock, Series A ("Mandatory Convertible Preferred Stock") at a price to the public and liquidation preference of $100.00 per share. The underwriters have separate 30-day options to purchase up to an additional 3,832,500 shares of Common Stock and up to an additional 1,312,500 shares of Mandatory Convertible Preferred Stock. The offerings are expected to close on May 27, 2020, subject to customary closing conditions.
Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
Open the BSX Page at Preferred Stock Channel »
|
|||||||||||||||||||||
|
|
Open the BSX Page at Preferred Stock Channel (in a new window) »
 Free BSX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
Avg. Broker Rec.
 
|
Strong Buy (3.57 out of 4) 58th percentile
(ranked higher than approx. 58% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
 |
